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Abstract:  Arboviruses are maintained in a natural cycle that requires blood-sucking 
arthropod and vertebrate hosts. Arboviruses are believed to persistently infect their 
arthropod host without overt pathology and cause acute infection with viremia in their 
vertebrate host. We have focused on elucidating how a specific arbovirus, Rift Valley fever 
(RVF) virus, causes cytopathic effect in cells derived from vertebrates and non-cytopathic 
infection in cells derived from arthropods. We demonstrate that the vertebrate virulence 
factor, NSs, is functional in arthropod cells but is expressed at significantly lower levels in 
infected arthropod versus infected vertebrate cells.  
Keywords: arbovirus; arthropod; NSs; non-structural protein; innate immunity; cytopathic 
effect; virulence factor 
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1. Introduction 
Rift Valley fever (RVF) virus is a mosquito-borne virus of the Bunyaviridae family, Phlebovirus 
genus, endemic to sub-Saharan Africa [1]. RVF virus causes disease in humans, as well as domestic 
ruminants such as cattle and sheep [1,2]. In humans, RVF is typically a self-limited febrile illness, 
although severe disease such as hemorrhagic fever and encephalitis, also occurs in a small percentage 
of human cases [1,2]. RVF in domestic ruminants results in abortion and high rates of mortality, 
especially in very young animals [1,2]. Localized flooding creates habitat for floodwater mosquitoes 
and is the initiating factor in RVF epizootics [3,4]. As a result, RVF epizootics are predictable weeks 
in advance based on satellite weather data [5,6]. The fact that RVF activity is predictable suggests that 
vaccination campaigns could be targeted to areas with imminent risk thereby allowing for prevention 
of epizootics. 
Culex and Aedes species mosquitoes are thought to be the most important vectors for transmission 
of RVF virus during epizootics [3,7,8]. It is not known where RVF virus resides during inter-epizootic 
periods, however transovarial transmission has been demonstrated in field-caught A. mc intoshi 
(reported originally as A. l ineatopennis) [3,9]. Despite the critical role mosquitoes have in 
transmission, and presumably in maintenance, of RVF virus, very little is known about the replication 
strategy of this virus in mosquitoes. Much of the molecular details of RVF virus replication and virus-
host interactions were obtained from studies performed in either vertebrate cell culture or vertebrate 
animals. In vertebrates, RVF virus infection is acute and lytic [2]. By contrast, RVF virus is thought to 
cause a non-lytic persistent infection of mosquitoes [3]. While it is believed that most arboviruses 
cause little or no detrimental effect on their natural mosquito host [10], RVF virus has been shown to 
decrease egg-laying, re-feeding efficiency and the lifespan of C. pipiens [11,12], a mosquito species 
that is known to vector RVF virus in the wild. 
The genome of RVF virus comprises three single-stranded RNA segments [13]. The S segment is 
ambi-sense and encodes for a non-structural protein (NSs) in the viral genomic sense (vRNA) and the 
nucleocapsid protein (N) in the viral genomic copy sense (cRNA) [13]. NSs is an indirect and a direct 
inhibitor of type I interferon (IFN) signaling in vertebrate cells. NSs down-regulates vertebrate host 
cell mRNA synthesis by sequestering components of a basal transcription factor complex, TFIIH [14]. 
As a consequence, -IFN and type I IFN-regulated genes are not expressed in response to virus 
infection [15]. NSs directly blocks IFN signaling through interaction with SAP30, which represses 
transcription of IFN [16]. NSs has also been recently shown to prevent RNA-activated protein 
kinase (PKR) from down-regulating translation in the presence of dsRNA [17,18]. While IFN 
signaling pathways are not present in mosquitoes, TFIIH is present, therefore it is possible that NSs 
acts as a transcriptional inhibitor in mosquitoes. 
We report on a comparison of RVF virus production and the synthesis of RVF virus proteins in 
arthropod and vertebrate cells. The envelope glycoproteins and N accumulate similarly regardless of 
source animal. However, NSs is expressed at significantly lower levels in arthropod cells as compared 
to vertebrate cells. The low level of NSs expression provides a mechanism for how RVF virus-infected 
mosquitoes escape down-regulation of basal transcription and suggests an explanation for the extreme 
diversity observed amongst the NSs of phleboviruses. Viruses 2010, 2                      
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2. Results 
2.1. RVF Virus Can Productively Infect Vertebrate and Arthropod Cells 
Hamster (Mesocricetus au ratus) [19], monkey (Cercopithecus a ethiops) [20], mosquito   
(A. albopictus) [21], sandfly (Lutzomyia longipalpis) [22] and fruitfly (Drosophila melanogaster) 
[23] cells were infected with RVF virus at an MOI of 1. The vertebrate and arthropod cell lines were 
grown at 35 C and 28 C, respectively. Supernatants were collected at 4, 8, 16 and 24 hpi for 
vertebrate and 8, 16, 24, and 48 hpi for arthropod cell lines. The collected virus was titered on C. 
aethiops cells. The cells were not washed following infection, therefore the initial timepoint in both 
the vertebrate and arthropod cells reflects the residual inoculum (Figure 1A and 1B). In both vertebrate 
cell lines, virus production was first observed at the 8 h timepoint, and continued out to the final 
timepoint at 24 h (Figure 1A). Extensive cytopathic effect (CPE) was observed at 24 h in both 
vertebrate cell lines, therefore no further timepoints were taken (data not shown). The arthropod cell 
lines required more time to secrete virus than vertebrate cells, with virus release first observed at 16 h 
in  A. albopictus cells (Figure 1B). Amongst the arthropod lines, A. albopictus cells secreted the 
highest final titers with the most rapid kinetics (Figure 1B). This result was expected since RVF virus 
has been shown to productively infect A. albopictus [24,25]. L. longipalpis cells took 24 h to produce 
virus and only increased the titer by 10
1 pfu/mL over baseline (Figure 1B). Although RVF virus can 
infect  L. longipalpis following intra-thoracic inoculation, this sandfly species was only marginally 
competent for transmission [26]. The D. m elanogaster cells yielded similar results to the   
L. longipalpis cells and virus production was not evident until 48 hpi (Figure 1B). No CPE was 
observed with any of the arthropod lines (data not shown). 
Figure 1. RVF virus productively infects vertebrate and arthropod cells. A.  M. 
auratus and C. aethiops and, B. A. albopictus, L. longipalpis and D. melanogaster cells 
were infected with RVF virus at an MOI of 1. The vertebrate lines were grown at 35 °C 
and the arthropod lines at 28 °C. Media was collected from the cells at the indicated times 
and the virus titer in the media was determined by plaque assay on C. aethiops cells. 
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2.2. Kinetics of RVF Virus Structural Protein Expression 
Production of the structural proteins N and Gn was monitored by immunofluorescence microscopy. 
Images were obtained for fields selected at random and total number of cells, infected cells, and 
infected cells that express Gn were counted as discussed in the materials and methods section. 
Evidence of infection was observed in greater than 85% of cells by 8 hpi in both vertebrate cell lines. 
Approximately 90% of the infected vertebrate cells expressed Gn (Table 1). By 24 hpi, nearly 100% of 
the vertebrate cells were infected and expressed Gn. By contrast, A. albopictus cells displayed a high 
percentage of infected cells (>95%) throughout the timecourse, however the percentage of infected 
cells expressing Gn was lower (Table 1). Only 51% of infected cells expressed Gn at 8 h, and 
expression did not peak until 24 h (Table 1). The slower rate of Gn expression in A. albopictus cells 
appears to correlate with slower virus production relative to the vertebrate cell lines (Figure 1B). All of 
the arthropod cell lines showed an approximately 10% reduction in Gn expression between 24 h and 
48h. Others have reported that the switch between acute and persistent phases of bunyavirus infection 
in insect cells occurs around 24 h [27–30], therefore this reduction in Gn positive infected cells could 
be because virion production is beginning to be down-regulated. 
Table 1. Gn expression in RVF virus infected cells. 
HPI  Source Specie (Cell Line)  Total Cells  % Infected
*  % Infected 
expressing Gn 
8  M. auratus  
(BSR-T7/5) 
393 85.0% 89.8%
16   790 99.1%  99.5%
24   365 99.5% 100%
48
†        
8  C. aethiops 
(Vero E6) 
609 83.1% 92.7%
16   344 96.5% 100%
24   295 97.3% 100%
48
†        
8  A. albopictus (C6/36)  529 97.9% 51.4%
16   655 98.0%  63.1%
24   380 96.3%  87.7%
48   547 96.3%  76.5%
8  L. longipalpis 
(LL-5) 
n.d. n.d.   n.d. 
16   69 100%  92.0%
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Table 1. Cont. 
HPI  Source Specie (Cell Line)  Total Cells  % Infected
*  % Infected 
expressing Gn 
24   114 99.1%  99.1%
48   193 97.9%  85.7%
8  D. melanogaster 
(S2) 
n.d. n.d.    n.d. 
16   229 93.0%  91.5%
24   272 98.5%  96.3%
48   97 92.8%  85%
Notes: (*) N expression was equated with RVF virus infection. (
†) Cytopathic effect prevented 
counting of 48 h timepoint. n.d. Not determined. 
2.3. NSs Is Expressed at Very Low Levels in Arthropod Cell Lines 
Production of the vertebrate virulence factor, NSs, was monitored by immunofluorescence 
microscopy. Cells were labeled with rabbit anti-N and mouse anti-NSs antibodies. Figure 2 represents 
images obtained from randomly selected fields of cells for the vertebrate and arthropod cell lines. In 
agreement with previous studies, filamentous structures that labeled with NSs antibody were localized 
to the nucleus in both vertebrate cell lines (Figure 2) [14,31,32]. At 8 hpi, greater than 65% of infected 
C. aethiops and M. auratus cells expressed NSs (Table 2). Expression of NSs increased to nearly 
90% of infected cells by 24 h in both C. aethiops and M. auratus cells (Table 2). By contrast, the vast 
majority of RVF virus-infected arthropod cells displayed NSs staining that was only slightly above the 
level found in mock-infected cells (Figure 2 and Table 2). Interestingly, although filamentous NSs 
staining was occasionally observed, the filaments were never found to be associated with nuclei   
(Table 2 and data not shown). 
The low level expression of NSs in the vast majority (≥98%) of arthropod cells (Table 2) made it 
difficult to identify positive cells upon visual inspection. Therefore, we analyzed the average intensity 
of NSs expression per cell as described in the materials and methods section. RVF virus-infected  
A. albopictus cells had an average cell intensity 2.1-fold mock, whereas infected M. auratus cells had 
an average cell intensity 7.3-fold mock. These data demonstrate that there is a clear difference in NSs 
expression level between arthropod and vertebrate cells. 
2.4. NSs is Not Detected in Mosquito Cells by Immunoprecipitation 
The low levels of NSs expression in arthropod cell lines could be due to low-levels of synthesis or 
rapid turnover of the protein. In order to distinguish between these possibilities, protein synthesis was 
assayed in M. auratus and A. albopictus cells by radioactive labeling of newly synthesized proteins. 
Additionally, a proteasome inhibitor (MG-132) was used in order to determine if low levels of NSs in 
arthropod cells were the result of degradation in the proteasome. Cells were either mock-infected or 
infected with RVF virus at an MOI of 1. At 20 hpi, proteins were labeled for 60 min with 
35S cysteine Viruses 2010, 2                      
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and methionine in either the presence or absence of MG-132. Labeled proteins were 
immunoprecipitated with either mouse anti-RVF virus (Figure 3A, lanes 3–5 and 11–13) or mouse 
anti-NSs (Figure 3A, lanes 6–8 and 14–16) followed by separation by SDS-PAGE.  
Figure 2. RVF virus infected arthropod cells express less NSs relative to vertebrate 
cells. M. auratus and C. aethiops, A. albopictus and L. longipalpis cells were infected 
with RVF virus at an MOI of 1. The vertebrate lines were grown at 35 °C and the 
arthropod lines at 28 °C. The images shown are from the 24 h and 48 h timepoints for the 
vertebrate and arthropod cells, respectively. The NSs and N antibody complexes were 
labeled with anti-mouse 488 (green) and anti-rabbit 594 (red), respectively. Scale bars 
represent 20 μm. 
 
 
Additionally, an aliquot of crude whole cell extract (WCE) from mock and RVF virus infected cells 
was run on the same gel (Figure 3A, lanes 1–2 and 9–10). A darker image of the lower portion of the 
gel is shown in Figure 3B. In M. au ratus cells, N and the envelope glycoproteins were 
immunoprecipitated by the polyclonal RVF virus antibody (Figure 3A, lanes 4–5) and these same Viruses 2010, 2                      
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bands were also prominent in the WCE lane (Figure 3A, lane 2 arrowheads), indicating that the cells 
are infected and actively synthesizing viral proteins. The mouse anti-RVF virus antibody does not 
appear to recognize NSs. When the mouse anti-NSs antibody is used, a band of approximately 30 kDa 
is apparent in infected cells (Figure 3A, lanes 7–8) but not mock infected (Figure 3A, lane 6) and this 
same band can also be observed in the infected WCE lane (Figure 3A lane 2 arrowhead). In agreement 
with previously published results [33], no differences were observed in the amounts of protein 
immunoprecipitated from cells that were labeled in the presence or absence of MG-132 (Figure 3A, 
compare lanes 4 and 5 and lanes 7 and 8) indicating that the proteasome does not contribute to the 
degradation of viral structural proteins. The band intensities for N and NSs were quantified, as 
described in the materials and methods section, and the ratio of immunoprecipitated N to NSs for  
M. auratus cells was 27:1. This value is not a result of differences in relative cysteine and methionine 
content as N and NSs have 1 and 5 cysteine residues, respectively, and both proteins have 12 
methionines. While this ratio is in part a function of the efficiency of immunoprecipitation with the 
two antibodies, it is obvious from the infected cell extract that more N is made relative to NSs. 
Therefore, although N and NSs genes are on the same genomic segment (S), the proteins are 
synthesized at dramatically different levels in M. auratus cells.  
A. albopictus cells were productively infected as indicated by the presence of N in the WCE  
(Figure 3A, lane 10 arrowhead) and N and envelope glycoproteins in the polyclonal RVF virus 
antibody lanes (Figure 3A, lanes 12–13). The envelope glycoproteins, Gn and Gc, migrate faster when 
the virus is grown in A. albopictus cells rather than M. auratus cells (Figure 3A, compare lanes 4 and 
12). This likely reflects structural differences in N- linked glycosyl groups between vertebrates and 
arthropods [34,35]. In contrast to the results obtained with M. auratus cells, no NSs was detected in 
the anti-NSs immunoprecipitate lanes (Figure 3A and 3B, lanes 15–16) or infected WCE lane (Figure 
3A, lane 10). Although the level of N in A. albopictus cells is lower than that obtained for M. auratus 
cells, NSs would have been detectable if it were made at the same level relative to N (27:1) as that 
found for M. auratus cells. Given the detection limit associated with this experiment, levels of NSs 
relative to N in A. albopictus cells are at minimum 2.2-fold lower than those found in M. auratus 
cells. Similar to the results found in M. auratus cells, MG-132 did not significantly affect the amounts 
of viral proteins in A. albopictus cells (Figure 3A, compare lanes 12 and 13 and lanes 15 and 16), 
indicating that the proteasome does not play a major role in viral protein degradation. 
Table 2. NSs expression in RVF virus infected cells. 
HPI  Source Specie 
(Cell Line) 
Total Cells  % Infected  % Infected 
expressing NSs 
8 
M. auratus 
(BSR-T7/5) 398 90.2% 66.9%
16   577 100% 88.4%
24   855 100% 92.7%
 Viruses 2010, 2                      
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Table 2. Cont. 
HPI  Source Specie 
(Cell Line) 
Total Cells  % Infected  % Infected 
expressing NSs 
48
†    
8 
C. aethiops 
(Vero E6)  324 90.1% 69.9%
16   309 98.7% 86.2%
24   418 98.1% 89.8%
48
†   
8 
A. albopictus 
(C6/36) 378 97.4% 0.272%
‡
16   482 96.1% 0.648%
‡
24   393 95.4% 1.07%
‡
48   328 91.2% 0.669%
‡
8 
L. longipalpis 
(LL-5) 138 71.7% 2.02%
‡
16   104 98.1% 1.96%
‡
24   227 94.7% 0.465%
‡
48   189 95.2% 1.11%
‡
8 
D. 
melanogaster 
(S2) n.d.  n.d. n.d.
16   288 95.1% 0.00%
‡
24   279 92.8% 0.00%
‡
48   83 100% 0.00%
‡
Notes: (*) N expression was equated with RVF virus infection. (
†) Cytopathic effect prevented 
counting of 48 h timepoint. (
‡) Due to the low expression levels only cells exhibiting NSs filaments 
were counted. n.d. Not determined. Viruses 2010, 2                      
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Figure 3. RVF virus infected A. albopictus cells synthesize lower amounts of NSs 
protein relative to M. auratus cells. M. auratus and A. albopictus cells were infected 
with RVF virus at an MOI of 1. At 20 hpi, proteins were labeled for 1 h with [
35S]-
methionine and cysteine either in the presence or absence of the proteasome inhibitor MG-
132. Viral proteins were immunoprecipitated with either an anti-RVF virus or anti-NSs 
antibody. An aliquot of labeled whole cell extract (WCE) was also run on the same 10% 
SDS-PAGE gel. A. The numbers on the left of the figure refer to the positions of molecular 
weight markers. On the right of the gel the positions of the envelope glycoproteins Gn and 
Gc, N and NSs are indicated. The asterisks indicate protein bands that are more intense in 
the WCE from mock-infected cells than RVF virus-infected cells. The arrowheads indicate 
the virus proteins in the WCE from infected cells. B. A darker image of the lower portion 
of the gel shown in A. 
 
 
The NSs of ZH548-MP12, the same strain of RVF virus as used in this study, is capable of shutting 
down global host protein synthesis in C. aethiops cells and appears to be the sole viral protein required 
for this effect [36]. Based on radiolabel incorporation in the WCE (Figure 3A, lanes 1–2 and 9–10) we 
observed a ~40% and ~25% reduction in protein synthesis in RVF virus-infected cells M. auratus and 
A. albopictus cells, respectively. Additionally, several proteins appeared to be visibly down-regulated 
in infected M. auratus and A. albopictus cells (asterisks in Figure 3A). While we do not know why 
cellular protein synthesis is reduced in RVF virus-infected A. a lbopictus cells, our Viruses 2010, 2                      
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immunofluorescence results (Figure 2 and Table 2) indicate that a small amount of NSs is made in  
A. albopictus cells. Additionally, others have successfully detected NSs from ZH548-MP12-infected 
mosquito cells by immunoprecipitation utilizing different antibodies, longer labeling times and a 
different mosquito cell line (AP-61 cells, derived from A. pseudoscutellaris) [37]. 
2.5. NSs Expression is Not Temperature-Sensitive 
The differences observed with respect to NSs expression could be due to the fact that the arthropod 
cell lines were grown at 28 °C and the vertebrate cell lines were grown at 35 °C. Thus, we tested the 
possibility that NSs expression is temperature-sensitive. M. auratus cells were infected with RVF 
virus at an MOI of 1 at 28 °C. At 24 hpi, cells were fixed and stained with rabbit anti-N and mouse 
anti-NSs antibodies. The percentage of infected cells that expressed NSs was ~43% (Figure 4A). 
Although the percentage of infected cells that expressed NSs was lower than that obtained when M. 
auratus cells were grown at 35 °C, it still represents a much higher percentage than observed in 
arthropod cells. Notably, the NSs did not localize to the nucleus and rather was found in puncta within 
the cytoplasm (Figure 4A). NSs is normally found in the cytoplasm early in an infection (≤8 hpi) 
(Figure 4B). Thus, the pattern of NSs staining for cells grown at 28 °C is potentially due to a cold-
sensitive step in NSs trafficking to the nucleus. Therefore, in M. a uratus cells NSs nuclear 
localization is temperature-sensitive, but NSs expression is not.  
Figure 4. NSs expression is not temperature-sensitive. M. auratus cells were infected 
with RVF virus at an MOI of 1. The cells were grown at A. 28 °C for 24 h or B. 35 °C for 
8 h. The NSs and N antibody complexes were labeled with anti-mouse 488 (green) and 
anti-rabbit 594 (red), respectively and the nuclei with DAPI (blue). Scale bars represent 
10 µm. 
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2.6. Plasmid-Expressed NSs in Mosquito and Fruitfly Cells Accumulates in the Nucleus 
A. albopictus cells were transfected with empty vector, NSs expression plasmid or GFP expression 
plasmid. At 36 h post-transfection, cells receiving either mock or NSs expression plasmid were fixed 
and stained with mouse anti-NSs. Cells transfected with the GFP expression plasmid were used to 
control for transfection efficiency. NSs expression was observed in ~13% of cells that were transfected 
with the NSs expression plasmid and the protein localized to nuclear filaments (Figure 5A). A stable 
D. melanogaster cell line with a NSs expression plasmid was also analyzed. The D. m elanogaster 
cells showed expression of NSs as nuclear filaments in 33% of cells (Figure 5B). Therefore, both  
A. albopictus and D. m elanogaster cells are competent to express NSs and the expressed protein 
localizes to the nucleus. Similar results have been obtained for expression of NSs using a Semliki 
Forest virus-derived expression system in AP-61 cells (derived from A. pseudoscutellaris) [38]. 
Figure 5. Arthropod cells transfected with a NSs expression plasmid efficiently 
express NSs. A. A. albopictus cells were transfected with an empty vector (Mock), NSs 
expression plasmid (pIB-NSs), or GFP expression plasmid (pIB-GFP). Cells were grown at 
28 °C for 36 h. B. A stable D. m elanogaster cell line was developed using an NSs 
expression plasmid with a copper-inducible metallothionein promoter (pMT-NSs). 
Expression was induced with 1 mM CuSO4 and cells were then grown at 28 °C for 16 h. 
The NSs antibody complex was labeled with anti-mouse 488 (green) and the nuclei with 
DAPI (blue). Scale bars represent 20 µm. 
 
2.7. Plasmid-Expressed NSs Inhibits Reporter Gene Expression in Fruitfly Cells 
To assess whether RVF virus NSs was functional in insect cells, D. melanogaster cells were 
transfected either with a luciferase or a -galactosidase expression plasmid (pS2MT-LUC or 
pS2MT-LacZ), and either empty expression plasmid (pMT) or NSs expression plasmid   Viruses 2010, 2                      
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(pMT-NSs). Expression from the metallothionein promoter (MT) was induced with copper 
sulfate and reporter levels were measured at 24 h post-induction (Figure 6A). Expression of NSs 
resulted in a 60–70% reduction in reporter expression relative to the empty expression plasmid 
control (Figure 6A). Levels of luciferase mRNA were also measured by semi-quantitative RT-
PCR (Figure 6B). The luciferase mRNA was approximately 10-fold lower in NSs expressing 
cells, relative to the vector alone control. These data suggest that RVF virus NSs is capable of 
acting as an inhibitor of transcription in D. melanogastercells. 
Figure 6.  Reporter gene expression is inhibited by NSs in D. melanogaster cells.  
A. D. melanogaster cells were transfected with expression plasmids for either luciferase 
(pS2MT-LUC) or -galactosidase (pS2MT-LacZ). In addition to the reporter plasmid, cells 
received either empty plasmid (pMT) or NSs expression plasmid (pMT-NSs). Expression 
of all genes was controlled by a copper-sensitive promoter (metallothionein). Reporter 
levels were measured at 24 h post-induction. The error bars reflect the standard errors of 
the mean for three independent experiments. B. D. m elanogaster cells were transfected 
with pMT (Mock) or pS2MT-LUC and either empty plasmid (pMT) or NSs expression 
plasmid (pMT-NSs). RNA was harvested and both actin and luciferase mRNA levels were 
examined by semi-quantitative RT-PCR. 
 
 
2.8. Discussion 
The NSs of RVF virus is expressed at a much lower level in arthropod cells than in vertebrate cells. 
Most significant is the low level of expression found in mosquito cells that were derived from   
A. albopictus [21], a mosquito that is competent for RVF virus transmission [24,25]. The reduced 
level of NSs expression cannot be explained by temperature differences between growth optima of 
vertebrate and arthropod cells nor can it be explained by inherent instability of NSs in arthropod cells. 
The most likely explanations are that the mRNA for NSs is either produced at lower levels than in 
vertebrate cells or that it is unstable. It is also possible that the NSs mRNA is not efficiently translated. 
Comparison of all of the phlebovirus proteins within strains of a particular virus and across virus 
species indicates that NSs exhibits the highest degree of variation [39,40]. In fact, the average 
percentage of amino acid identity for pairwise NSs comparisons across the phleboviruses transmitted Viruses 2010, 2                      
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by mosquitoes and sandflies is ~19% [40]. By comparison, N, which is encoded on the same genomic 
segment, yields average pairwise comparison values of ~54% [40]. Clearly, NSs does not experience 
the same selective pressures as N. A strain of RVF virus, known as Clone 13, has a large internal 
deletion within the NSs ORF which removes ~90% of the coding sequence [39,41]. This strain is a 
plaque-purified clone derived from a strain (74HB59) isolated from a non-fatal human case of RVF 
[41]. Clone 13 is avirulent in rodents and does not productively infect vertebrate cells that are 
competent for IFN signaling [33,41,42]. However, Clone 13 is capable of growing in A. albopictus 
cells (C6/36) [24,43] and can produce a disseminated infection in several Culex and Aedes species 
following either an infectious bloodmeal or intra-thoracic inoculation [24,41,43]. Therefore, NSs is not 
required for growth of RVF virus in mosquitoes and our data indicate that NSs is poorly expressed in 
A. albopictus cells. It is possible that NSs plays little or no role in maintenance of RVF virus in the 
mosquito host, and thus the main selective pressure on the NSs gene in the mosquito host is for 
reduced expression. 
Interestingly, it has been demonstrated that expression of dsRNA derived from either the complete 
S segment or the N gene severely reduces the ability of RVF virus to replicate in cells derived from  
A. pseudoscutellaris [38]. By contrast, expression of dsRNA derived from the NSs gene had no effect 
on the ability of RVF virus to replicate in these cells [38]. These results were interpreted as a failure of 
NSs RNA to induce an effective RNAi response against the virus [38]. However, another interpretation 
of these data is that an effective RNAi response was mounted, however degradation of NSs mRNA 
does not adversely affect virus replication in A. pseudoscutellaris cells. Along these lines, there is no 
data from viruses of the Bunyaviridae family that addresses whether the encapsidated genome and 
antigenome are sensitive to degradation mediated by interfering RNAs [38,44,45]. All published data 
on RNAi-mediated restriction of bunyavirus replication can be interpreted as being primarily caused 
by degradation of mRNAs essential for production of the replicative proteins (RNA-dependent RNA 
polymerase and/or N) [38,44,45]. We hypothesize that genome and anti-genome are not sensitive, 
since base-pairing of the interfering RNAs with the genome would be hindered by bound N. Our 
interpretation is supported by the fact that Clone 13 can replicate in both mosquitoes and cells derived 
from mosquitoes [24,41,43]. Assessing the levels of NSs mRNA in the presence or absence of NSs 
dsRNA would indicate which interpretation is correct.  
In order to maintain a persistent infection in arthropod hosts, there must be strong selective pressure 
on arboviruses to minimize the detrimental effects of replication and accessory proteins, such as NSs. 
Bunyamwera virus (family Bunyaviridae, genus Orthobunyavirus) also has an NSs that is involved 
in down-regulation of vertebrate host cell transcription [46]. The Bunyamwera virus NSs is encoded in 
an ORF that overlaps that of the N gene, and shares no sequence homology with RVF virus NSs [13]. 
This protein is expressed in arthropod cells, however in contrast to its effect on vertebrate cells, it does 
not down-regulate transcription [46,47]. Our data suggests that a different mechanism exists for 
overcoming the detrimental effects of RVF virus NSs on arthropod cells. RVF virus NSs is poorly 
expressed in arthropod cells, but the protein is functional, as indicated by reduced reporter gene 
expression in D. melanogaster cells and by the decrease in protein synthesis in A. albopictus cells. 
RVF virus NSs has been shown to interact with human p44 and XPD, both components of the basal 
transcription factor, TFIIH [14]. NSs sequesters human p44 and XPD in filaments within the nucleus 
and as a result other TFIIH proteins fail to localize to the nucleus and are degraded in the cytoplasm Viruses 2010, 2                      
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[14]. Expression of NSs from a plasmid in vertebrate [14,32] and arthropod cells (Figure 5) [37,38] 
results in nuclear localization of NSs, and in some cells, formation of filaments. NSs does not appear 
to have a nuclear localization signal (NLS), and it is believed to enter the nucleus by virtue of the NLS 
on p44 [14,32]. It is not yet known whether the NSs of RVF virus binds arthropod p44. However,  
C. quinquefasciatus, A. aegypti and D. melanogaster p44 are 50–53% identical and 67–69% similar 
to human p44. Many arboviruses encode proteins that are involved in down-regulation of host gene 
expression (reviewed in [48]). Several of these proteins have demonstrated activity in cells derived 
from their arthropod host, although presumably their main purpose is to counteract mammalian innate 
immune responses (reviewed in [48]). Since most arboviruses persistently infect their arthropod hosts, 
there will no doubt be many other mechanisms uncovered in the future for the blunting of the 
detrimental effects of these host gene expression inhibitors in arthropods. 
Arboviruses must replicate efficiently in disparate hosts in order to be maintained in nature. 
Therefore, it is not surprising that many have been shown to adapt to growth in one of their hosts 
through acquisition of specific amino acid changes [49]. Our results indicate that RVF virus NSs is 
differentially expressed in vertebrate and arthropod cells and this differential is likely critical for its 
fitness in each host. To our knowledge, the differential expression of NSs represents the first example 
of phylum-specific expression of an arbovirus protein. The mechanism by which NSs is expressed at 
lower levels in arthropod cells as compared to vertebrate cells is not yet known. However our results 
are consistent with either a failure to accumulate NSs mRNA or a failure to translate NSs mRNA. NSs 
can form nuclear filaments when expressed from a plasmid in A. albopictus and D. m elanogaster 
cells (Figure 5), or from a Sindbis virus-based expression system in A. pseudoscutellaris cells [38], 
demonstrating that the poor expression and failure to form nuclear filaments in RVF virus-infected 
arthropod cells is either a property of the virus or due to an activity in arthropod cells that only 
manifests in the context of infection.  
NSs appears to contribute to the RVF virus–induced cytopathology in vertebrate cells [36]. A 
recombinant RVF virus strain that lacked NSs was found to produce just as much virus as the parental 
strain but with less cytopathology in Vero E6 (C. aethiops) cells [36]. RVF virus has been shown to 
cause morbidity and mortality in C. pipiens [11,12,50]. We observed an overall decrease in protein 
synthesis and identified proteins that were obviously down-regulated in infected A. albopictus cells 
(Figure 3A). Additionally, we have found that over a 72 h timecourse, A. albopictus cells infected 
with RVF virus remain viable but fail to proliferate (CCS and SRG, unpublished data). It is possible 
that RVF virus persistence in mosquitoes is dependent on low levels of NSs expression to lessen the 
detrimental effects of transcriptional inhibition. The sole function of the RVF virus NSs gene may be 
to counteract the innate immune response of mammals in order to generate the prolonged viremia 
necessary for transmission to naïve mosquitoes [10]. If this is the case, then strains of RVF virus that 
lack the ability to express NSs should be less detrimental to mosquitoes than strains that can express 
NSs. Furthermore, strains that over-express NSs would be expected to result in increased mortality of 
mosquitoes. These predictions have important implications for the development of live-attenuated 
vaccines against RVF virus. NSs inhibits pathways in vertebrates that have no correlates in arthropods, 
notably the ability to inhibit PKR and IFN signaling. Thus, it may be possible to make a vaccine 
strain of RVF virus that is attenuated in mammalian hosts but is virulent for mosquitoes.  Viruses 2010, 2                      
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3. Experimental Section  
3.1. Cells and Virus 
The M. auratus cells (BSR-T7/5) were obtained from Dr. K. Conzelmann (Max-von Pettenkofer-
Institut, Munchen, Germany), the C. aethiops cells (Vero E6) from the Centers for Disease Control 
and Prevention (Atlanta, GA), the A. albopictus (C6/36) and D. melanogaster (S2) cells were from 
the American Type Culture Collection (Manassas, Virginia), and the sandfly cells (LL-5) from Dr. I. 
Novella (University of Toledo). The ZH-548 MP-12 vaccine strain of RVF virus was obtained from 
Dr. R. Tesh (World Reference Center of Emerging Viruses and Arboviruses) and was handled under 
BSL-2 conditions. 
3.2. Antibodies 
The hybridomas for the NSs (3C3-1-1) and Gn (R1-4D4-1-1) antibodies were obtained from Dr. G. 
Ludwig at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). 
The mouse anti-RVF virus antibody was obtained from Dr. P. Rollin (CDC). The rabbit anti-N 
antibody was developed against bacterially expressed full-length N. 
3.3. Construction of pIB-GFP, pIB-NSs and pMT-NSs 
The GFP gene was amplified with Taq polymerase using primers GFPNSSDel5   
(5’-GATATCAATGGTGAGCAAGGGCGAGGAG-3’) and GFPNSSdel3   
(5’-GATATCTTACTTGTACAGCTCGTCCAT-3’), then cloned into pIB/V5-His TOPO® TA. The 
template for amplification of the NSs gene was pTrRVFV-S, which represents a full-length clone of 
the S segment of the ZH-501 strain of RVF virus [51]. In order to make pIB-NSs, the NSs gene was 
amplified with Taq polymerase using primers NSSBAM5 (5’-GGATCCATGGATTACTTTCCTGTG-
3’) and NSSXHO3 (5’-CTCGAGCTAATC AACCTCAACAAATCC-3’), then cloned into pIB/V5-
His TOPO® TA. In order to make pMT-NSs, the NSs gene was amplified with Taq polymerase using 
primers RVFNSsSpe5 (5’- ACTAGTATGGATTACTTTCCTGTG -3’) and pMTRVFnssXho3   
(5’- CTCGAGCTAATCAACCTCAACAAATC-3’), and cloned into pCR-TOPO®, then subcloned 
into the pMT-V5/HisA. 
3.4. Plasmids and Transfection 
The pVAX1, pIB/V5-His TOPO® TA, pCR-TOPO® and pMT-V5/HisA plasmids were obtained 
from Invitrogen Corp. The construction of the NSs and GFP expression plasmids, pIB-NSs, pIB-GFP 
and pMT-NSs, is described in supplemental methods. The reporter plasmids, pS2MT-LUC and 
pS2MT-LacZ, have been described elsewhere [52]. A. albopictus cells were plated at a density of 1.0 
x10
5 cells per well on glass coverslips in 24-well culture plates. Cells were transfected using 
TransIT®-LT1 (Mirus Bio, LLC, Madison, WI) 24 h after plating. Plasmids were used at 2.5 µg per 
well and transfectant at 2.5 µL per well. D. m elanogaster cells were transfected and expression 
induced as described previously [52]. Viruses 2010, 2                      
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3.5. Infections and Virus Titration 
Confluent cell monolayers of M. auratus, C. aethiops, A. albopictus, or L. longipalpis cells on 
glass coverslips in 24-well plates were infected with RVF virus at an MOI of 1. Vertebrate cells were 
incubated at 35 °C and arthropod cells at 28 °C, unless otherwise indicated. Media was harvested at the 
timepoints indicated in the text and stored at -80 °C. Cells were fixed and processed for 
immunofluorescence as described elsewhere [53]. In order to determine virus concentration, harvested 
media was thawed and serially diluted. Dilutions were used to infect confluent C. aethiops monolayers 
grown in 96-well plates. Plates were scored for cytopathic effect (CPE) at 1 week post-infection. 
3.6. Quantification of Indirect Immunofluorescence Microscopy Data 
Images were obtained utilizing an Olympus BX fluorescence microscope equipped with a digital 
camera. For each cell line and timepoint, two randomly selected fields were photographed. Cells were 
counted using the Cell Counter Plug-in for ImageJ (NIH) using the following methodology to 
determine percent expression of N, Gn and NSs. DAPI positive cells were marked and counted to 
determine the total cell count. The DAPI markers were overlaid on the corresponding N image and 
positive cells were marked and counted, thus providing the percentage of total cells that express N. For 
all experiments the percentage of cells expressing N was arbitrarily equated with percentage of cells 
infected with RVF virus. The N markers were overlaid on the corresponding NSs image. N positive 
cells that were also NSs positive were marked and counted, thus providing the percentage of infected 
cells that express NSs. The methodology was repeated to obtain the percentage of infected cells that 
express Gn. 
3.7. Intensity Quantification of NSs Expression 
Using Adobe Photoshop, the green channel from the NSs image was merged with the corresponding 
red channel from the N image. Cell outlines for individual cells and small groups of cells were selected 
on the red channel (N). The corresponding selection was cut from the green channel (NSs) and pasted 
into a new image with a black background. A histogram was created for the intensity of green 
fluorescence (NSs) using the Color Histogram utility in ImageJ. The total intensity of green 
fluorescence (NSs) from the histogram was divided by the number of cells selected to determine an 
average intensity of green fluorescence (NSs) per cell, therefore providing a relative value of NSs 
expression. 
3.8. Radioactive Immune-Precipitation Assay 
Confluent monolayers of M. auratus and A. albopictus cells in 6-well plates were infected with 
RVF virus at an MOI of 1. Proteins were labeled at 16 hours post-infection (hpi), and 
immunoprecipitated as previously described [54]. Immune precipitated proteins were resolved by 
SDS-PAGE, the gel was fixed, dried and placed in a PhosphoImager cassette. Screens were scanned 
with a Storm PhosphoImager and band intensities were quantified using ImageQuant software 
(Amersham Pharmacia Biotech, Piscataway N.J.). Viruses 2010, 2                      
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3.9. Reporter Gene Expression 
Enzymatic assays to determine -galactosidase and luciferase levels were done as previously 
described [52]. For RT-PCR, total RNA was isolated with Trizol, digested with RQ1 DNAse, 
repurified with RNAsy columns per the manufacturer's instruction, and quantiated by 
spectrophotometry and gel electrophoresis. For reverse transcription, Superscript II (Invitrogen) was 
used in concert with 2.5 g total RNA and oligo-dT primers per the manufacturer's instructions. PCR 
reactions were done with 10-fold serial cDNA dilutions, 200 nM gene-specific primers, and 30 cycles. 
4. Conclusions 
The RVF virus virulence factor, NSs, is differentially expressed in cells derived from arthropods 
versus vertebrates. The envelope glycoproteins and N accumulate similarly regardless of source 
animal. The low level of NSs expression provides a mechanism for how RVF virus-infected 
mosquitoes escape down-regulation of basal transcription and suggests an explanation for the extreme 
diversity observed amongst the NSs of phleboviruses. Reduced NSs expression may correlate with 
persistence, and thus these results have implications for development of live-attenuated vaccines 
against RVF. 
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